Ex-AstraZeneca boss David Brennan waives right to bonus
Monday 16 July 2012
The former boss of pharmaceuticals giant AstraZeneca has waived his entitlement to a 2012 annual bonus and has been denied performance-related share awards for the last two years, it emerged today.
Astra chief executive David Brennan stepped down in June after slashing full-year profit hopes and failing to tackle a shortage of blockbuster drugs as patents expire.
The FTSE 100 Index firm said Mr Brennan, who was with Astra for 36 years, will receive 11 months' salary worth £914,122 and will retain shares awarded in 2010 worth £1.5 million.
But he has waived any bonus entitlement for the portion of 2012 in which he worked for the group, while share awards made to Mr Brennan in 2011 and 2012 will be forfeited.
Mr Brennan has amassed a pension pot worth £14 million, according to the group's annual report, and could still receive further share awards from previous years.
He was one of a number of chief executives this year to succumb to shareholder pressure to step down, along with Aviva's Andrew Moss and Trinity Mirror's Sly Bailey.
Astra's shares fell around 6% between the time Mr Brennan took charge in 2006 and his departure last month.
The UK's second biggest drugs maker has struggled in recent months after it lost patent cover on antipsychotic drug Seroquel and tests on ovarian cancer drug Olaparib proved it to be ineffective.
Results for the first three months of the year blamed a "loss of exclusivity" for a 38% drop in pre-tax profits to 2.1 billion US dollars (£1.3 billion). The group subsequently lowered its target for full-year earnings per share.
Astra's so-called "patent cliff" - when revenues drop off as patents expire - is particularly steep as breast cancer drug Arimidex has already lost patent protection while acid reflux treatment Nexium and biggest seller Crestor will lose patent protection in the next four years.
Singer was ordered not to 'blow her rape whistle' in song 'Vegas'
Mr and Mrs Smith star admits she's 'never been comfortable on-screen'
Co-creator Mark Gatiss dropped some very intriguing hints ahead of the BBC drama's return next year
It is a crazy place to play in summer, writes Paul Scholes
It was all about Liz’s cocaine-fuelled brainwave, 'The Metwork'
- 1 American-born Boris Johnson refuses to pay hefty US tax bill
- 2 Lee Evans announces his retirement from comedy on The Jonathan Ross Show
- 3 John Smid: Former leader of US ‘gay cure’ group has just married a man
- 4 These grandmas smoking weed for the first time are wonderful
- 5 Pastafarian former porn star Asia Lemmon allowed to wear colander in driving licence photo
Duchess of Alba dead: Billionaire Spanish duchess who lived life by her own rules, dies at 88
These grandmas smoking weed for the first time are wonderful
Mike Nichols dead: The Graduate director dies suddenly following cardiac arrest
Woman opens professional cuddling shop – gets 10,000 customers in first week
US fire chief caught on camera 'refusing to help crash victims because they're black'
Rochester by-election: Ukip gains second MP as Tory defector Mark Reckless holds seat
'Muslims pre-date Columbus in discovering America,' says Turkish president Erdogan
France 'blocks' Russian sailors from boarding a warship
Former Tory PM Sir John Major says 'we would not have an NHS without migrants'
Rochester by-election: Labour MP Emily Thornberry resigns after posting white van and England flags tweet
G20 summit: David Cameron warns Vladimir Putin that Russia's relationship with the West is at a 'fork in the road' over Ukraine
iJobs Money & Business
Voluntary Only - Expenses Reimbursed: Reach Volunteering: Age Concern Slough a...
Voluntary Only - Expenses Reimbursed: Reach Volunteering: Crossroads Care is s...
£20000 - £25000 per annum + OTE £35,000: SThree: We consistently strive to be ...
£50000 - £90000 per annum + benefits: Ampersand Consulting LLP: Markit EDM (CA...